All News

It may not be possible to write a rulebook on how to innovate, but there is no harm in reading attempts to do so.

Wine and biotechnology come together in yet another genome project.

European Union has voted to continue funding embryonic stem cell research after a heated debate at the European Parliament on Tuesday.

IBM offers a few details of its new consultancy service for R&D management. Pity about the jargon.

Cuts in federal funding have forced UC Berkeley's RAD Lab to seek industry funding. But the money may not be enough to plug the gap.

The international treaty on plant genetic resources needs a gesture of trust to repair the atmosphere of suspicion that has developed, argues Emile Frison from the International Plant Genetic Resources Institute.

The future of European Union funded embryonic stem cell research hangs in the balance after a heated debate at the European Parliament on Tuesday.

A spin off from ETH-Zürich has devised a new generation of detection equipment that could help in the fight against terrorism. The company is now seeking investment and possible partnerships to take the technology to a commercial level.

USA Today reports declining R&D budgets in the USA, albeit in, it seems, just one tech sector.

The EU wants 25 per cent of transport energy will come from biofuels by the year 2030 – and is backing research that it will help it get there.

A team of researchers from ETH-Zürich is looking for investment for their spin-off company, XpresSys, to commercialise novel protein expression technology. The technology has the potential to revolutionise screening process for new drugs.

It may have started from a low base, but the Indian biotech industry is hurtling past the global growth rate. And overseas companies are anxious to get in on the action.

For a bunch of IT experts, the EU's IST World has come up with a baffling web site, especially when the idea is to make life easy for beginners.

Indian firms are training large numbers of patent agents - with their eye on the large number of companies abroad looking for cheaper patenting.

Biology Information Open Source's promoter, Richard Jefferson, asserts that BIOS is explicitly modelled after the Open Source initiative in software. But science is grounded in open exchange and the sharing of information, so what is the point of BIOS and other initiatives such as Science Commons?